Primary Carnitine Deficiency as a Treatable Cause of Heart Failure in Young Patients

Meral Kayıkçıoğlu1, Benay Özbay2, Burcu Yağmur1

  • 1Department of Cardiology, Ege University Faculty of Medicine, İzmir, Turkey.

Insights

Primary carnitine deficiency is an overlooked inherited metabolic disorder that causes heart failure in young adults. Early diagnosis and oral carnitine treatment can prevent disease progression and arrhythmias.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Genetics

Background:

  • Non-ischemic dilated cardiomyopathy is a common cause of heart failure in young adults, often presumed idiopathic.
  • Metabolic defects are potential underlying etiologies in these patients.

Observation:

  • Primary carnitine deficiency is an inherited metabolic disease that can lead to cardiomyopathy.
  • This case report details the diagnosis and successful treatment of primary carnitine deficiency in an index patient and his brother.

Findings:

  • Oral carnitine replacement therapy is an effective treatment for primary carnitine deficiency.
  • Carnitine therapy can halt the progression of heart failure and prevent life-threatening arrhythmias.

Implications:

  • Highlights primary carnitine deficiency as a treatable cause of heart failure in young adults.
  • Emphasizes the importance of considering inherited metabolic disorders in the etiology of unexplained cardiomyopathy.
  • Suggests early screening and intervention for primary carnitine deficiency can improve patient outcomes.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
44